A team of scientists at Gladstone and UCSF created a new genetic roadmap that reveals hundreds of hidden players in HIV infection, including two proteins that stop HIV in its tracks.
Posts by Gladstone Institutes
New research from Yadong Huang’s team reveals how the APOE4 gene disrupts brain circuits early in life, identifying a reversible pathway in Alzheimer’s disease.
Researchers in the lab of Christina Theodoris have built a temporal foundation model that forecasts cell state trajectories across the human lifespan.
Did you know that you can listen to our latest articles? Check out this episode on a new AI model that predicts how cells age.
Listen on Spotify or wherever you get your podcasts!
The Pershing Square Foundation’s MIND Prize recognizes individuals making significant contributions to neuroscience, cognition, and neurodegenerative disease research. Ryan Corces was selected for his innovative approach to uncovering biological mechanisms that drive Alzheimer’s disease.
Cool new work from my @gladstoneinst.bsky.social and @ucsanfrancisco.bsky.social on haplosufficient genes
pubmed.ncbi.nlm.nih.gov/41929339/
🌟 A big thank you to our April Reviewer of the Month, Dr Kruthika Iyer, for her contributions to our scientific community! Dr Iyer is a Bioinformatics Fellow at @gladstoneinst.bsky.social, whose work focuses on the genetic architecture of aging and complex disease.
www.nature.com/commsbio/ref...
Gladstone scientists, in collaboration with NVIDIA, developed a new AI model—MaxToki—that can predict how individual cells change as we age. By analyzing gene activity across the human lifespan, this model is helping uncover the genes that drive aging and age-related diseases.
New research from Yadong Huang’s team reveals how the APOE4 gene disrupts brain circuits early in life, identifying a reversible pathway in Alzheimer’s disease.
Lennart Mucke shares insights on the potential biological connections between two very different neurological conditions.
"It's not just a building. It's more than space. It represents an opportunity to scale our impact on solving the diseases we're focused on at Gladstone."
Deepak Srivastava talks about Gladstone's expansion in Mission Bay.
Last week, we welcomed Daniel J. Drucker for the Lloyd “Holly” Smith Distinguished Lecture, where he shared the science behind GLP-1 medicines and their growing impact across human health.
Thanks to everyone who joined us and helped make it such an engaging event.
What if we could finally understand which tiny changes in our DNA actually cause disease?
Gladstone scientists are bringing together cutting-edge AI models and powerful molecular tools to tackle one of the biggest challenges in science: decoding the human genome.
Scientists have found a way to create cancer killing CAR-T cells inside the body. This eliminates the costly, time-consuming manufacturing process that has kept these therapies out of reach of cancer patients around the world.
@j-eyquem.bsky.social
On World Parkinson’s Day, we’re shining a light on the science behind Parkinson’s disease—and what it could mean for future treatments.
Their platforms are paving the way to new treatments and medicines for some of the harshest diseases, from Alzheimer’s to cancer to HIV.
At Gladstone, a leader in this fast-moving field, our scientists aren’t simply using artificial intelligence in their work—they’re creating some of the world’s most advanced AI models in biomedical research.
Scientists, too, are using AI to better understand how human bodies work and what goes wrong in disease. Yet, the use of AI in science remains a bit of a mystery for the average person.
Artificial intelligence, or #AI, is all around: it can draft emails, control your home thermostat, generate videos, and even drive cars. 🧵
Melanie Ott and Nadia Roan are central to a groundbreaking effort to create the world’s first map of how HIV affects the immune system at a single-cell level.
👏 👏 Congratulations to Gladstone investigator @ryancorces.bsky.social who has been named a 2026 winner of the Pershing Square Foundation’s MIND Prize.
This award recognizes next-frontier thinkers who are uncovering a deeper understanding of the brain and cognition.
MaxToki, a new AI model developed at @gladstoneinst.bsky.social, learned how every cell type in the body ages. Now, it can predict which genes drive that aging, pointing toward new targets for heart disease and dementia. gladstone.org/news/new-ai-...
Such an amazing lecture from @danieljdrucker.bsky.social for our annual Holly Smith Distinguished Lecturer for 2026 @gladstoneinst.bsky.social
🚨 NEW 🚨
"Two decades of induced pluripotent stem cell research: From discovery to diverse applications" by Shinya Yamanaka
What if AI didn’t just give answers—but helped scientists ask better questions?
At Gladstone, researchers like Seth Shipman are pushing AI and molecular tools to uncover what we don’t yet understand about disease—and turn uncertainty into insight.
It’s Graduate Student Appreciation Week!
Our graduate students push ideas forward, navigate challenges with creativity, and ask the questions that lead to what’s next. Just as importantly, they bring a spirit of collaboration that makes Gladstone thrive.